A call to close the gaps in how biologics reach Saudi IBD patients.
Saudi Journal of GastroenterologySaudi J Gastroenterol. 2026; 32(1); pp. 79-80
Zaki Alhashimalsayed
SGA Briefing
An editorial commentary examining shortfalls and disparities in how biologic therapies are being used for inflammatory bowel disease across Saudi Arabia.
Read the full article
This links to the publisher’s open-access copy of record. A self-hosted PDF will appear here once one is on file.